{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:24:00Z","timestamp":1789370640767,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T00:00:00Z","timestamp":1436572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"EU-FP7","award":["FP7-KBBE-2007-2A"],"award-info":[{"award-number":["FP7-KBBE-2007-2A"]}]},{"name":"EU-JPND","award":["01ED1201A"],"award-info":[{"award-number":["01ED1201A"]}]},{"name":"Alzheimer-Forschungs-Initiative e.V.","award":["AFI 12851"],"award-info":[{"award-number":["AFI 12851"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00415-015-7837-x","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T08:09:58Z","timestamp":1436515798000},"page":"2305-2311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD"],"prefix":"10.1007","volume":"262","author":[{"given":"Franc","family":"Llorens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eriton Gomes","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Gotzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Thune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Ricardo Mendes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"key":"7837_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev.pathmechdis.3.121806.154326","volume":"3","author":"A Aguzzi","year":"2008","unstructured":"Aguzzi A, Sigurdson C, Heikenwaelder M (2008) Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3:11\u201340","journal-title":"Annu Rev Pathol"},{"key":"7837_CR2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp.64.3.298","volume":"64","author":"N Andreasen","year":"1998","unstructured":"Andreasen N, Vanmechelen E, Van d V, Davidsson P, Hesse C, Tarvonen S, Raiha I, Sourander L, Winblad B, Blennow K (1998) Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer\u2019s disease: a community based follow up study. J Neurol Neurosurg Psychiatry 64:298\u2013305","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7837_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, Yamada M, Mizusawa H, Kitamoto T, Klug G, McGlade A, Collins SJ, Nishida N (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175\u2013178","journal-title":"Nat Med"},{"key":"7837_CR4","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/prca.200800006","volume":"2","author":"M Bibl","year":"2008","unstructured":"Bibl M, Lewczuk P, Esselmann H, Mollenhauer B, Klafki HW, Welge V, Wolf S, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J (2008) CSF amyloid-beta 1-38 and 1-42 in FTD and AD: biomarker performance critically depends on the detergent accessible fraction. Proteomics Clin Appl 2:1548\u20131556","journal-title":"Proteomics Clin Appl"},{"key":"7837_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.mp.4001967","volume":"12","author":"M Bibl","year":"2007","unstructured":"Bibl M, Mollenhauer B, Lewczuk P, Esselmann H, Wolf S, Trenkwalder C, Otto M, Stiens G, Ruther E, Kornhuber J, Wiltfang J (2007) Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Mol Psychiatry 12:671\u2013680","journal-title":"Mol Psychiatry"},{"key":"7837_CR6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K Blennow","year":"2003","unstructured":"Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol 2:605\u2013613","journal-title":"Lancet Neurol"},{"key":"7837_CR7","first-page":"a006833","volume":"3","author":"DW Colby","year":"2011","unstructured":"Colby DW, Prusiner SB (2011) Prions. Cold Spring Harb Perspect. Biol 3:a006833","journal-title":"Biol"},{"key":"7837_CR8","doi-asserted-by":"crossref","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, Raeber A, Varges D, Kim Y-S, Satoh K, Collins S, Zerr I (2015) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt\u2013Jakob disease. Mol Neurobiol. doi: 10.1007\/s12035-015-9133-2","DOI":"10.1007\/s12035-015-9133-2"},{"key":"7837_CR9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12035-014-8709-6","volume":"51","author":"M Cramm","year":"2015","unstructured":"Cramm M, Schmitz M, Karch A, Zafar S, Varges D, Mitrova E, Schroeder B, Raeber A, Kuhn F, Zerr I (2015) Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol Neurobiol 51:396\u2013405","journal-title":"Mol Neurobiol"},{"key":"7837_CR10","doi-asserted-by":"crossref","unstructured":"Gao L, Tang H, Nie K, Wang L, Zhao J, Gan R, Huang J, Zhu R, Feng S, Duan Z, Zhang Y, Wang L (2014) Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis. Int J Neurosci [Epub ahead of print]","DOI":"10.3109\/00207454.2014.961454"},{"key":"7837_CR11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I (2007) Creutzfeldt\u2013Jakob disease in Germany: a prospective 12-year surveillance. Brain 130:1350\u20131359","journal-title":"Brain"},{"key":"7837_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133:713\u2013726","journal-title":"Brain"},{"key":"7837_CR13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-2009-1075","volume":"17","author":"S Jesse","year":"2009","unstructured":"Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M (2009) Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer\u2019s disease and Creutzfeldt\u2013Jakob disease. J Alzheimers Dis 17:541\u2013551","journal-title":"J Alzheimers Dis"},{"key":"7837_CR14","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1007\/s00415-013-7047-3","volume":"260","author":"L Kaerst","year":"2013","unstructured":"Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I (2013) Cerebrospinal fluid biomarkers in Alzheimer\u2019s disease, vascular dementia and ischemic stroke patients: a critical analysis. J Neurol 260:2722\u20132727","journal-title":"J Neurol"},{"key":"7837_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-130995","volume":"38","author":"L Kaerst","year":"2014","unstructured":"Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I (2014) Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson\u2019s disease, and Alzheimer\u2019s disease. J Alzheimers Dis 38:63\u201373","journal-title":"J Alzheimers Dis"},{"key":"7837_CR16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00415-014-7334-7","volume":"261","author":"T Kasai","year":"2014","unstructured":"Kasai T, Tokuda T, Ishii R, Ishigami N, Tsuboi Y, Nakagawa M, Mizuno T, El-Agnaf OM (2014) Increased alpha-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease. J Neurol 261:1203\u20131209","journal-title":"J Neurol"},{"key":"7837_CR17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymeth.2012.03.016","volume":"56","author":"N Kruse","year":"2012","unstructured":"Kruse N, Schulz-Schaeffer WJ, Schlossmacher MG, Mollenhauer B (2012) Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of alpha-synuclein and other proteins in cerebrospinal fluid. Methods 56:514\u2013518","journal-title":"Methods"},{"key":"7837_CR18","doi-asserted-by":"crossref","first-page":"e1004741","DOI":"10.1371\/journal.pgen.1004741","volume":"10","author":"DF Lazaro","year":"2014","unstructured":"Lazaro DF, Rodrigues EF, Langohr R, Shahpasandzadeh H, Ribeiro T, Guerreiro P, Gerhardt E, Krohnert K, Klucken J, Pereira MD, Popova B, Kruse N, Mollenhauer B, Rizzoli SO, Braus GH, Danzer KM, Outeiro TF (2014) Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet 10:e1004741","journal-title":"PLoS Genet"},{"key":"7837_CR19","doi-asserted-by":"crossref","unstructured":"Llorens F, Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, Grau-Rivera O, Nos C, Gelp\u00ed E, Del R\u00edo JA, Zerr I, Ferrer I (2014) Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt\u2013Jakob disease. Neuropathol Appl Neurobiol. doi: 10.1111\/nan.12175","DOI":"10.1111\/nan.12175"},{"key":"7837_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I, Ng J, Schulz-Schaeffer W, Kretzschmar HA, McLean PJ, Trenkwalder C, Sarracino DA, Vonsattel JP, Locascio JJ, El-Agnaf OM, Schlossmacher MG (2008) Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213:315\u2013325","journal-title":"Exp Neurol"},{"key":"7837_CR21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00702-010-0543-z","volume":"118","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Esselmann H, Roeber S, Schulz-Schaeffer WJ, Trenkwalder C, Bibl M, Steinacker P, Kretzschmar HA, Wiltfang J, Otto M (2011) Different CSF beta-amyloid processing in Alzheimer\u2019s and Creutzfeldt\u2013Jakob disease. J Neural Transm 118:691\u2013697","journal-title":"J Neural Transm"},{"key":"7837_CR22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00702-012-0784-0","volume":"119","author":"B Mollenhauer","year":"2012","unstructured":"Mollenhauer B, Trautmann E, Otte B, Ng J, Spreer A, Lange P, Sixel-Doring F, Hakimi M, Vonsattel JP, Nussbaum R, Trenkwalder C, Schlossmacher MG (2012) alpha-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system. J Neural Transm 119:739\u2013746","journal-title":"J Neural Transm"},{"key":"7837_CR23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 58:192\u2013197","journal-title":"Neurology"},{"key":"7837_CR24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3233\/JAD-143099","volume":"45","author":"C Pan","year":"2015","unstructured":"Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J (2015) Diagnostic values of Cerebrospinal Fluid T-Tau and Abeta42 using meso scale discovery assays for Alzheimer\u2019s disease. J Alzheimers Dis 45:709\u2013719","journal-title":"J Alzheimers Dis"},{"key":"7837_CR25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, Forstl H, Kurz A (2003) Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt\u2013Jakob disease from other dementias. Mol Psychiatry 8:343\u2013347","journal-title":"Mol Psychiatry"},{"key":"7837_CR26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Saanchez-Valle R, Mitrovaa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I (2006) CSF tests in the differential diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 67:637\u2013643","journal-title":"Neurology"},{"key":"7837_CR27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","volume":"254","author":"P Sanchez-Juan","year":"2007","unstructured":"Sanchez-Juan P, Sanchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichova D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn CM, Zerr I (2007) Influence of timing on CSF tests value for Creutzfeldt\u2013Jakob disease diagnosis. J Neurol 254:901\u2013906","journal-title":"J Neurol"},{"key":"7837_CR28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","volume":"68","author":"C Schmidt","year":"2011","unstructured":"Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I (2011) Rapidly progressive Alzheimer disease. Arch Neurol 68:1124\u20131130","journal-title":"Arch Neurol"},{"key":"7837_CR29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","volume":"71","author":"T Skillback","year":"2014","unstructured":"Skillback T, Rosen C, Asztely F, Mattsson N, Blennow K, Zetterberg H (2014) Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt\u2013Jakob disease: results from the Swedish Mortality Registry. JAMA Neurol 71:476\u2013483","journal-title":"JAMA Neurol"},{"key":"7837_CR30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","volume":"184","author":"T Stewart","year":"2014","unstructured":"Stewart T, Liu C, Ginghina C, Cain KC, Auinger P, Cholerton B, Shi M, Zhang J (2014) Cerebrospinal fluid alpha-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort. Am J Pathol 184:966\u2013975","journal-title":"Am J Pathol"},{"key":"7837_CR31","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","volume":"135","author":"K Stoeck","year":"2012","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc\u2019h K, Schelzke G, Karch A, van Duijn CM, Zerr I (2012) Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt\u2013Jakob disease and rapid dementias: a longitudinal multicentre study over 10\u00a0years. Brain 135:3051\u20133061","journal-title":"Brain"},{"key":"7837_CR32","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","volume":"135","author":"K Stoeck","year":"2012","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc\u2019h K, Schelzke G, Karch A, van Duijn CM, Zerr I (2012) Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt\u2013Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 135:3051\u20133061","journal-title":"Brain"},{"key":"7837_CR33","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","volume":"289","author":"T Sunderland","year":"2003","unstructured":"Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM (2003) Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289:2094\u20132103","journal-title":"JAMA"},{"key":"7837_CR34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WAD.0b013e31823899cc","volume":"26","author":"F Tateno","year":"2012","unstructured":"Tateno F, Sakakibara R, Kawai T, Kishi M, Murano T (2012) Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease. Alzheimer Dis Assoc Disord 26:213\u2013216","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"7837_CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","volume":"349","author":"T Tokuda","year":"2006","unstructured":"Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, Locascio JJ, Schlossmacher MG, El-Agnaf OM (2006) Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease. Biochem Biophys Res Commun 349:162\u2013166","journal-title":"Biochem Biophys Res Commun"},{"key":"7837_CR36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/CCLM.2011.086","volume":"49","author":"AC Harten van","year":"2011","unstructured":"van Harten AC, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YA, van der Flier WM, Scheltens P (2011) Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 49:353\u2013366","journal-title":"Clin Chem Lab Med"},{"key":"7837_CR37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3233\/JAD-1999-1606","volume":"1","author":"EB Van","year":"1999","unstructured":"Van EB, Green AJ, Pals P, Martin JJ, Cras P (1999) Decreased levels of Amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt\u2013Jakob disease patients. J Alzheimers Dis 1:419\u2013424","journal-title":"J Alzheimers Dis"},{"key":"7837_CR38","doi-asserted-by":"crossref","first-page":"e53250","DOI":"10.1371\/journal.pone.0053250","volume":"8","author":"M Wennstrom","year":"2013","unstructured":"Wennstrom M, Surova Y, Hall S, Nilsson C, Minthon L, Bostrom F, Hansson O, Nielsen HM (2013) Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLoS ONE 8:e53250","journal-title":"PLoS ONE"},{"key":"7837_CR39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt\u2013Jakob disease. Ann Neurol 43:32\u201340","journal-title":"Ann Neurol"},{"key":"7837_CR40","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van DC, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt\u2013Jakob disease. Brain 132:2659\u20132668","journal-title":"Brain"},{"key":"7837_CR41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","volume":"55","author":"I Zerr","year":"2000","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro CJ, Knight RS, Bernheimer H, Cardone F, Delasnerie-Laupretre N, Cuadrado CN, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz BA, Budka H, Laplanche JL, Will RG, Poser S (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 55:811\u2013815","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7837-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7837-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:10:29Z","timestamp":1566951029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7837-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["7837"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7837-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]}}}